February 12, 2015 — A new stent for treating cardiovascular disease that incorporates a polymer invented at Rutgers, The ...
Stents
This channel includes news and new technology innovations for stents, also called vascular scaffolds. Stents are used to help prop open a vessel treated by balloon angioplasty because of the barotrauma caused by the extreme stretching of vessel walls. The stent enables to vessel to heal in an open position with collapsing. Drug eluting stents (DES) are coated in anti-proliferative drugs to precent scar tissue growth which can cause restenosis and occlude the vessel. DES require antiplatelet therapy because the drug carrier polymer on DES can cause thrombus inside the stent, even years after treatment, which is why bare metal stents are still used in some patients. This page includes news on coronary stents, carotid stents, peripheral stents, bioresorbable stents, and renal stents.Â
February 3, 2015 — Coronary bypass graft surgery commonly used to treat patients with coronary heart disease results in ...
February 2, 2015 — Biosensors International Group has announced a distribution agreement with Veryan Medical Ltd. for Bi ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
The America College of Cardiology has released its list of key late-breaking clinical trials at the ACC 2015 meeting in ...
January 8, 2015 — Stentys announced that the Self-Apposing Stent has been implanted more than 10,000 times in patients ...
January 5, 2015 — InspireMD, Inc. announced results from two important clinical trials. Thirty-day results from the ...
December 31, 2014 — Reva Medical initiated patient enrollment with its Fantom bioresorbable drug-eluting scaffold. The ...
December 30, 2014 — Wearable technologies, possible changes to stenting practices, state legislation on energy drinks ...
December 22, 2014 — Veniti Inc. announced that it has enrolled the first United States patients in the Virtus trial of ...
December 10, 2014 — In the first successful United States trial of a bioabsorbable polymer stent, the Boston Scientific ...
Nov. 14, 2014 — Micell Technologies Inc. announced commercialization plans for its MiStent Sirolimus Eluting Absorbable ...
Nov. 13, 2014 — Optimizing the treatment of coronary artery disease with a new foundation for future stent innovations ...